NIFTY
-1.25  -0.01%
 10564.05
S&P BSE SENSEX
-11.71  -0.03%
 34415.58
Sun Pharmaceutical Industries Ltd.
NSE : SUNPHARMA BSE : 524715 ISIN code : INE044A01036
on 20-Apr-2018
NSE
-3.9    -0.77%
Rs. 505.30
 
Days Low
Rs. 502.5
Days High
Rs. 509

Open Rs. 508.5
 
52 week Low
Rs. 433.15
52 week High
Rs.659.9
 
 
Bid :                 0.00 (0)
Offer :        505.40 (18)
BSE
Rs.505.40
-3.4    -0.67%
on 20-Apr-2018
BSE
-3.4    -0.67%
Rs. 505.40
 
Days Low
Rs. 502
Days High
Rs. 509

Open Rs. 509
 
52 week Low
Rs. 432.7
52 week High
Rs.659.45
 
 
Bid :                 0.00 (0)
Offer :        505.40 (18)
NSE
Rs.505.30
-3.9    -0.77%
 
 
Last Price (Rs.)  505.40 Value  64409593.00
Net Change (Rs.)  -3.40 Best Buy  0.00
Volume  127619 Best Sell  505.40
Prev.Close (Rs.)  508.80 Best Quantity  0
Open (Rs.)  508.50 Sell Quantity  18
High (Rs.)  509.00 52-Week High (Rs.)  659.90
Low (Rs.)  502.50 52-Week Low (Rs.)  433.15
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  1212617.94
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Currents Investments400.10 735.60 939.30 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Cipla 584.40 470512 172.31 48.22 0.34
Piramal Enterprises 2608.00 470154 879.19 57.93 0.80
Cadila Healthcare 388.00 397212 73.15 60.04 0.82
Biocon 637.25 382350 110.72 24.55 0.16
Ranbaxy Labs. 859.90 366028 1.53 0.00 0.00
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2017Sep 2017Jun 2017
Net Sales20452.3018238.4018025.20
Operating Profit2117.908082.90-1470.20
PBDT1470.906787.10-11809.60
Net Profit405.005770.50-12909.90
More> 
 
Company News
4/19/2018 12:00:00 AM
Sun Pharma’s arm hikes stake in Ranbaxy Malaysia
4/19/2018 12:00:00 AM
Sun Pharma moves up on arm hiking stake in Ranbaxy Malaysia
4/18/2018 12:00:00 AM
Announcement under Regulation 30 (LODR)-Updates on Acquisition
More>
 
Ratios
   Earnings Per Share (Rs)-0.15 
   Book NAV/Share(Rs)86.98 
   PAT Margin (%)-0.45 
   Asset Turnover(x)0.23 
   PER(x)0.00 
   Yield(%)0.51 
   EV/Core EBITDA(x)280.28 
   M Cap / Sales21.44 
   Net Sales Growth(%)-0.46 
   PAT Growth(%)96.79 
   Total Debt/Equity(x)0.29 
   Current Ratio(x)0.58 
   Quick Ratio(x)0.37 
   Total Debt/Mcap(x)0.04 
More>